Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dd57ffd8e58e37d47fe4e82cd147bb39 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14143 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1754 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-1072 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
filingDate |
2020-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dae69ffac981b1b931356ee1d42109f7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8869d823602fb02235c1aac67b15a74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bac7b5c72a30473eb2b01aebadacea43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3278824065fdbeacef56cbf1e646d4da http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a36e04b4d64ce6cc89673c9fcfadbb6 |
publicationDate |
2021-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2021005604-A1 |
titleOfInvention |
Long-acting igf-1 or igf-1 variants and methods of producing same |
abstract |
Compositions which include polypeptides comprising at least one carboxy-terminal peptide (CTP) of chorionic gonadotropin attached to the carboxy terminus or amino terminus of an insulin-like growth factor 1 (IGF-1) or IGF-1 variant. Polynucleotides encoding the same are disclosed. Pharmaceutical compositions and pharmaceutical formulations comprising the polypeptides and polynucleotides of the invention and methods of using and producing same are also disclosed. |
priorityDate |
2019-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |